BRANDT ERIC 4

What Happened

• Eric Brandt, a director of Lam Research (LRCX), sold a total of 54,500 shares in multiple open-market transactions executed on June 11, 2026. The total reported proceeds were $19,118,358 (weighted-average price ≈ $350.80).
• Individual trade prices reported in the filing span roughly $337.00 to $364.37 (many line items use weighted-average prices because each line aggregates multiple trades). These were sales (transaction code S), and at least some of the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026—indicating preplanned sales rather than discretionary trading.

Key Details

• Transaction date: June 11, 2026; Form 4 filed June 15, 2026 (filed within the standard two business days, i.e., timely).
• Shares sold: 54,500; total proceeds: $19,118,358; approximate weighted-average price: $350.8 per share.
• Price details: individual reported prices (or weighted averages) range from about $337.00 up to $364.37; numerous footnotes in the filing (F2–F27, etc.) show many line items are weighted-average prices from multiple trades—see the filing for per-line ranges.
• Notable footnotes: F1 notes a Rule 10b5-1 trading plan (adopted Feb 6, 2026). F3 indicates some amounts reported may include shares subject to unvested restricted stock units.
• Shares owned after the transactions: not specified in the summary provided here (refer to the full Form 4 for post-transaction holdings).

Context

• These were outright sales (S). Sales executed under 10b5-1 plans are prearranged and common for insiders to systematically monetize holdings; while they reduce insider ownership, they are not, by themselves, a clear signal about the director’s view of the company. Purchases typically carry more informational weight for signaling confidence.